- $1.32bn
- $295.63m
- $2.31bn
- 86
- 98
- 18
- 75
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 6-K | 20-F | 20-F | 20-F | 20-F |
Standards: | — | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 350 | 676 | 1,679 | 4,608 | 2,308 |
Cost of Revenue | |||||
Gross Profit | 80.1 | 234 | 1,097 | 3,408 | 921 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 302 | 488 | 627 | 1,568 | 1,524 |
Operating Profit | 47.7 | 188 | 1,051 | 3,041 | 783 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 38.1 | 162 | 1,035 | 3,057 | 818 |
Provision for Income Taxes | |||||
Net Income After Taxes | 28.5 | 134 | 865 | 2,480 | 653 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 29.5 | 129 | 749 | 1,820 | 430 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 29.5 | 129 | 749 | 1,820 | 430 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.081 | 0.349 | 1.95 | 4.71 | 1.15 |